cloudy.png
Sunday December 8th, 2019 11:36AM

Early study results suggest 2 Ebola treatments saving lives

By The Associated Press
Related Articles
  Contact Editor

WASHINGTON (AP) — Two of four experimental Ebola drugs being tested in Congo seem to be saving lives, international health authorities announced Monday.

The preliminary findings prompted an early halt to a major study on the drugs and a decision to prioritize their use in the African country, where a yearlong outbreak has killed more than 1,800 people.

The early results mark "some very good news," said Dr. Anthony Fauci of the U.S. National Institutes of Health, which helped fund the study. With these drugs, "we may be able to improve the survival of people with Ebola."

The two drugs — one developed by Regeneron Pharmaceuticals and the other by NIH researchers — are antibodies that work by blocking the virus.

While research shows there is an effective albeit experimental vaccine against Ebola — one now being used in Congo — no studies have signaled which of several potential treatments were best to try once people became sick. During the West Africa Ebola epidemic several years ago, studies showed a hint that another antibody mixture named ZMapp worked, but not clear proof.

So with the current outbreak in Congo, researchers compared ZMapp to three other drugs — Regeneron's compound, the NIH's called mAb114 and an antiviral drug named remdesivir.

On Friday, independent study monitors reviewed how the first several hundred patients in the Congo study were faring — and found enough difference to call an early halt to the trial. The panel determined that the Regeneron compound clearly was working better than the rest, and the NIH antibody wasn't far behind, Fauci explained. Next, researchers will do further study to nail down how well those two compounds work.

The data is preliminary, Fauci stressed. But in the study, significantly fewer people died among those given the Regeneron drug or the NIH's — about 30% compared to half who received ZMapp. More striking, when patients sought care early — before too much virus was in their bloodstream — mortality was just 6% with the Regeneron drug and 11% with the NIH compound, compared to about 24% for ZMapp, he said.

Among people who receive no care in the current outbreak, about three-fourths die, said Dr. Michael Ryan of the World Health Organization. All of Congo's Ebola treatment units have access to the two drugs, he added, saying he was hopeful that the news would persuade more patients to seek care — as soon as symptoms appear.

Tackling Congo's outbreak has been complicated both by conflict in the region and because many people don't believe Ebola is real and choose to stay at home when they're sick, which spurs spread of the virus.

"Getting people into care more quickly is absolutely vital," Ryan said. "The fact that we have very clear evidence now on the effectiveness of the drugs, we need to get that message out to communities."

Fauci said Regeneron and Ridgeback Biotherapeutics, which has licensed the NIH compound, told authorities enough doses are readily available.

One issue researchers will have to analyze: Occasionally people who receive the Ebola vaccine still become sick, including some in the treatment study, which raises the question of whether their earlier protection inflated the drugs' survival numbers.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: U.S. News, Associated Press (AP), AP National News, AP Online National News, Top U.S. News short headlines, Top General short headlines, AP Health, AP Business
© Copyright 2019 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Early study results suggest 2 Ebola treatments saving lives
Early study results suggest 2 experimental Ebola drugs being tested in Congo may be saving lives
2:19PM ( 4 minutes ago )
Suspect in Norway mosque attack smirks in court appearance
A Norwegian gunman suspected of killing his stepsister and storming an Oslo mosque appeared in court with a smirk on his bruised face
2:09PM ( 14 minutes ago )
The Latest: Medical group says rules hamper health care
A major medical association says new guidelines that could be used to deny green cards to immigrants who use public assistance like Medicaid will have drastic consequences on health care
1:59PM ( 24 minutes ago )
Associated Press (AP)
Oklahoma latest to grapple with online school problems
An investigation into the founders of an online charter school in Oklahoma is just the latest in a series of similar probes taking place across the country
1:16PM ( 1 hour ago )
Federal New York lockup draws new scrutiny in Epstein death
A federal lockup known for housing famous inmates has drawn a measure of infamy with the apparent suicide of its latest notorious guest: financier Jeffrey Epstein
1:16PM ( 1 hour ago )
Democrat Galloway launches Missouri gubernatorial campaign
Missouri Auditor Nicole Galloway is launching her Democratic campaign for governor by highlighting her efforts to uncover waste and fraud
1:09PM ( 1 hour ago )
AP National News
Stocks move broadly lower as trade war anxiety lingers
U.S. stocks moved broadly lower in morning trading Monday as investors opened the week heading for safety
11:41AM ( 2 hours ago )
Italian politicians ponder when to hold no-confidence vote
Leading politicians in Italy's Senate are hastily returning from their summer vacations to determine when a crucial no-confidence vote will be held on Premier Giuseppe Conte's populist coalition
11:18AM ( 3 hours ago )
Portugal rations gas as tanker drivers strike over pay
Portugal is rationing gas as tanker truck drivers begin an open-ended strike over pay
11:16AM ( 3 hours ago )
AP Business
Suspect in Norway mosque attack smirks in court appearance
A Norwegian gunman suspected of killing his stepsister and storming an Oslo mosque appeared in court with a smirk on his bruised face
2:09PM ( 14 minutes ago )
The Latest: Medical group says rules hamper health care
A major medical association says new guidelines that could be used to deny green cards to immigrants who use public assistance like Medicaid will have drastic consequences on health care
1:59PM ( 24 minutes ago )
Defense may holds keys to Oklahoma's title hopes
Defense could holds keys to Oklahoma's title hopes
1:51PM ( 32 minutes ago )
AG says 'irregularities' found at jail where Epstein died
Attorney General William Barr says the Justice Department has "serious irregularities" at the federal jail where Jeffrey Epstein took his own life over the weekend
1:48PM ( 35 minutes ago )
Trump overhauls endangered species protections
The Trump administration has rolled out some of the broadest changes in decades to enforcement of the landmark Endangered Species Act, which critics contend could speed extinction for some struggling plants and animals
1:46PM ( 37 minutes ago )